timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol]
timolol hemihydrate
RxCUI: 1992305
What the CMS Formulary Data Shows for timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol]
Per the CMS 2026 Part D formulary file, timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] (RxNorm concept RXCUI 1992305, generic name timolol hemihydrate) appears on 5 distinct formulary files spanning 809 Medicare Part D plan offerings - 16% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 4 to Tier 4, with a cross-plan average of Tier 4.
Real-world access to timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 6,978 Part D beneficiaries filled timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] in 2023, with total plan-and-beneficiary spending of $4,906,851 and an average per-beneficiary annual cost of $703.19. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] today.
Coverage Details
- Formularies covering
- 5
- Plans covering
- 809
- Coverage rate
- 16%
- Tier range
- Tier 4, Non-Preferred
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 6,978
- Total spending
- $4,906,851
- Avg per beneficiary
- $703.19
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol]
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
| AARP Medicare Rx Saver from UHC (PDP) | UNITEDHEALTHCARE INS. CO. & UHC INS. CO. OF NY | T4 | No | No | $0 | - |
Medicare Advantage Plans (MA-PD) Covering timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol]
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] covered by Medicare Part D?
Yes, timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] is covered by 809 Medicare Part D plans (16% of all Part D formularies).
What tier is timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] on Medicare Part D plans?
timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] averages Tier 4 across Part D plans, ranging from Tier 4 to Tier 4.
Does timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] require prior authorization?
0% of Part D formularies require prior authorization for timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol]?
In 2023, total Medicare Part D spending on timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] was $4,906,851, covering 6,978 beneficiaries. The average spend per beneficiary was $703.19.
Read our methodology - how this data is sourced, computed, and verified.